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Abstract—Bioactive peptides have been investigated largely for many biofunctional properties. The aim of this research was to 
determine the inhibitory activity of ultrafiltration (UF) and gel filtration (GF) fractions of gelatin derived from bone of Pangasius 
catfish against dipeptidyl peptidase IV (DPP-IV). Previous studies have shown that gelatin from skins of salmon, hake, halibut, 
milkfish, tilapia and bone of pangasius catfish have the activity in DPP-IV inhibition. While, as inhibitor, most of previous and recent 
studies shown that separation and fractination of gelatin hydrolysate increase their activity. This research was conducted in three 
stages including gelatin hydrolysates fractination by ultrafiltration (UF), UF fraction loaded into gel filtration (GF) and DPP-IV 
inhibition measurement. The fish bone gelatin was hydrolyzed using flavourzyme at three enzyme/substrate ratios (E/S of 3%, 6% 
and 9%) with incubation times 4, 6, and 8 h. Then, the hydrolysates fractioned by ultrafiltration with 3 kDa cutoff membrane 
continued with Superfine G-25 sephadex column (65 cm x 3 cm, flow rate 1 mL/min). The result shown that both group of fractions i.e 
UF and GF have inhibitory activity regarding their capacity to inhibit DPP-IV.  The UF fraction >3 kDa derived from 9% (E/S) ratio 
for hdyrolysis were superb as DPP-IV inhibitor than other fractions, the highest one also has bioactivity higher than other previous 
fish gelatin fractions.  
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I. INTRODUCTION 
Bioactive peptides is specific protein fragments (usually 
range from 2 to 20 amino acid residues) that acting as 
sources of amino acids sequence with numerous potential 
physiological functions including  opioid, antioxidant, 
immunomodulatory, antibacterial, antithrombotic and 
antihypertensive activity [1]. Now, it has been investigated 
largerly for other biofunctional properties, such as anticancer 
[2] and antidiabetes [3]. As antidiabetes, most of studies 
have been concern to the activity of bioactive peptide contra 
dipeptidyl peptidase IV (DPP-IV)  [4], [5]. DPP-IV is an 
enzyme degrades glucose-dependent insulinotropic 
polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), 
which are both of them is a precusor for creating incretin. 
The degradation of GIP and or GLP-1 causes the incretin 
loses their fuction, while this hormone has a significant 
aspect related managing of blood glucose homeostasis, and it 
was encouraging in therapeutic target of type 2 diabetic 
(T2D) treatment and prevention [3], [6], which is most of 
T2D has been focused on incretin regulation as a novel 
therapy, recently [7]. In addition, majority of diabetes patient 
is T2D (more than 90% diabetic patients is affect T2D [8]) 
and some of drugs for treating T2D by incretin approach 
have been trade commercially  [9]. So that why, currently, 
research and study related producing and characterizing of 
bioactive peptide as inhibitor of DPP-IV have been increase 
dramatically. 
The bioactive peptides as DPP-IV inhibitor has been 
inspected from broad sources, like microbial product and 
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natural food protein [4]. Diprotin A and B, a microbial 
bioactive peptide provide supreme inhibitory activity toward 
DPP-IV [10], regardless the utilization of food based protein 
as parent of bioactive peptide is a favorable choice, 
paticularly for safety and health consideration. The food 
based protein that have been used to produce of bioactive 
peptide covering chiken egg, beef meat, soy protein, cheese, 
milk, corn, fish meat and gelatin [1], [4], [11]. We definitely 
agreed that gelatin is the most promosing source of bioactive 
peptide including for DPP-IV inhibitor. Despite, it has been 
used widely in food, phramaceutical and cosmetic products, 
fortunately, gelatin usually extracted from by-product or 
useless materials [12],[13]. In addition, the inhibitory 
activity of bioactive peptide againts DPP-IV influence by 
their proline existency, whilst this amino acid is second 
abundance in gelatin [5].  
Number of studies have been done by using of gelatin as 
source of bioactive peptide for DPP-IV inhibitor. Almost all 
type of gelatin sources have shown inhibitory activity 
against DPP-IV covering traditional and alternative origin 
[14], [15], [16]. Even though, most of gelatin or derivates is 
from mammalians, such as cow and pig [17], but some 
research were used gelatin from alternative source in order 
to seeking a bioactive peptide for DPP-IV inhibitor [15], 
[16], [18], [19]. It is caused by socio-religion and cultural 
aspects, where are gelatin derived from porcine is 
unacceptable in Muslim and Jewish communities, whereas 
bovine or cow gelatin is not accepted by Hindu community 
[20]. The gelatin from alternative sources which has been 
tested for generating bioactive peptide as DPP-IV inhibitor 
monopolized by fish gelatin. They were involved gelatin 
from skin of salmon [18], [19] hake, halibut, milkfish, nila 
tilapia [16] and pangasius catfish [15]. Bioactive peptide 
derived from warm-water fish were higher than other in 
order to inhibit DPP-IV action [16]. 
The bone of Pangasius catfish was most auspicious as 
source of gelatin and their derivatives. This type of fish was 
was confirmed that they was provided highest in gelatin 
yield, camparable in physical characterictics within 
commercial gelatin and they have ash content which is 
confirm with standard of gelatin [21], [22].  In Indonesia, 
Pangasius catfish spread out in Sumatera and Borneo island, 
where are their consumption and production rate has been 
increased continuously every years. The Ministry of Marine 
Affairs and Fisheries of Indonesia was targeted the 
Pangasius catfish production in 2018 reaching 604.587 ton 
[23], it would inflicted to they waste especially bones, which 
is contribute about 12.44% for total fish weight. In addition, 
our previous study also shown that the gelatin from bone of 
Indonesia Pangasius catfish has DPP-IV inhibitory activiy, 
and it was above of bovine and fish skin gelatin activities 
[15]. Consequently, it is required to further analysis of this 
gelatin hydrolysate in order to discover a superior and 
sustainable source of  bioactive peptide with DPP-IV 
inhibitory activity. 
The aim of this research was to determine the inhibitory 
activity of ultrafiltration (UF) and gel filtration (GF) 
fractions of fish bone of gelatin hydrolysate against DPP-IV. 
It is because most of previous studies were described that the 
inhibitory activity increased after the separation and 
fractionation. Although, the activity might be scale down on 
GF fraction coincide with their protein reduction, however 
this process is needed in order to obtain the pure component 
or peptide sequence as well as to increase the spesific 
activity. For functional food and drug agents, the high 
activity with the lower concentration is necessary.    
II. MATERIAL AND METHOD 
A. Materials and Reagents 
The gelatin solution from bone of Pangasius catfish 
(Pangsius sutchi) which was extracted on our previous study 
[15]. The Hydroxyproline Colorimetric Assay Kit 
(containing 10 mL Oxidation buffer, 0.6 mL Chloramin T 
concentrate, 5 mL Perchloric acid/Isopropanol solution, 5 
mL p-dimethylaminobenzaldehyde (DMAB) concentrate (in 
DMSO) and 0.1 mL Hydroxyproline standard) was 
purchased from Biovision Inc. (Milpitas, CA, USA). The 
food-grade proteolytic enzyme, Flavourzyme 250 mL (from 
Aspergillus oryzae, 500 U/g) was manufactured by 
Novozyme Corp. (Bagsvaerd, Denmark). Dipeptidyl 
Peptidase IV human (D4943, expressed in baculovirus 
infected Sf9 cells), Gly-pro-p-nitroanilide, Bovine serum 
albumin (BSA), Superfine sephadex G-25 and Diprotin A 
were purchased from Sigma Aldrich (St. Louis, MO, USA). 
Sitagliptin phosphate monohydrate was from European 
Pharmacopoeia (Strasbourg, France). The Citric acid and 
Trichloro acetic acid (TCA) were donated by Merck KgaA 
(Darmstadt, Germany). Marker proteins was purchased from 
Promega Cooperation (Madison, WI, USA). Other chemicals 
and reagents used were of analytical grade and it is available 
commercially.  
B. Gelatin Confirmation Test 
Before hydrolysis the gelatin existance was confirmed by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) through discontinues Tris/HCl/ glycine buffer 
system [21]. A 20 μL liquid solution of fish bone gelatin 
loaded into gel on electrophoresis apparatus (ATTO, Tokyo, 
Japan), running at voltage of 50 V for 90 min. During this 
anaysis, marker protein was also loaded as standard of 
molecular weight range. Then, the gelatin yield calculated as 
the ratio of weight dried fish bone gelatin to the total weight 
of leached bone (ossein) on wet basis [21]. Finally, the 
hydroxyproline recovery analyzed as extraction yield and 
selected as part of indicator of gelatin amount.  It was 
calculated by the method described in Koli et al. [24] and 
Atma et al. [25] with some modifications.   
C. Gelatin Hydrolysis 
In the hydrolysis stage, the fish bone gelatin was 
incubated at 50 oC for 10 minutes prior enzymatic hydrolysis. 
The hydrolysis reaction was started by the addition of 
Flavourzyme at various enzyme/substrate ratios (E/S: 3, 6 
and 9%) and incubation times (4, 6 and 8 hours). The 
hydrolysis process was stopped by heating the reaction in the 
boiling water (100 oC) for 10 minutes and cooled in ice 
water for 20 minutes immediatelly, both for enzyme 
inactivation. Then, adjusted to pH 7.0 with addition of 1 M 
NaOH and centrifugated (Hettich, Tuttlingen, Germany) at 
10.000 g, 4 oC for 15 minutes. The supernatant or gelatin 
hydrolysate was collected and stored at -18 oC. The degree 
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of hydrolysis (DH) measured by quantify of remain protein 
in hydrolysate divided total protein in gelatin (whitout 
hydrolysis) as adopted from Mahmoodani et al. [26] which is 
using 20% Trichloroacetic acid (TCA) (w/v) to allow 
precipitation, Bradford solution (commasie brilliant blue 
G250:ethanol :phosphoric acid; 2:1:2; w/v/v) to protein 
quantification and Bovine serum albumin (0.1-1 mg/mL) to 
determine standard qurve.  
D. Ultrafiltration (UF) 
The fish bone gelatin hydrolysates were fractionated by 
ultrafiltration (PLBC Ultracel-PL Millipore, Merck KGaA, 
Darmstadt, Germany) with vertical regenerated cellulose 
membrane having molecular weight cut-off 3 kDa combined 
centrifugation at 4000 g and 4 oC for 45 minutes. The 
fraction was collected as follow: >3 kDa, hydrolysates 
retained without passing through 3 kDa membrane and ≤3 
kDa, hydrolysates permeating through the 3 kDa membrane. 
All fractions namely UF fractions were collected and stored 
in refrigerator until further analysis and fractination.  
E. Gel Filtration (GF)  
The UF fraction which has highest activity as a DPP-IV 
inhibitor was fractionated using a gel filtration column. A 5 
mL fraction solution was loaded in a column (65 cm x 3 cm) 
containing a stationary phase of the G-25 sephadex gel. The 
column was equiliberated prior of fraction loading  by using 
aquabides (mobile phase).  When the UF fraction solution 
entered the stationary phase, then aquabides added again. 
Samples and mobile phases passing through the column at a 
speed of 1 mL/min are manually collected with a test tube 
per 5 mL expressed as sub-fractions. Furthermore, each 
protein profile was measured using a spectrophotometer at 
wavelengths 214 nm and 280 nm. Based on this protein 
pattern, subfractions are then mixed into several fractions to 
measure their activity as DPP-IV inhibitors. 
F. Determination of DPP-IV Inhibitory Activity 
Inhibitory activity of UF and GF fractions were measured 
based on their capacity to inhibit DPP-IV in order to use 
subtrate i.e Gly-Pro-p-nitroanilide [27]. It was performed 
using microplate reader (Multiscan Ex, Champaign, IL, USA) 
mated with 96-well microplate and interpreted by the color 
amplification of reacted solution absorbance at visible 
wavelength [5]. The procedure of analysis is according to 
our previous study [15]. In this quantification, Sitagiliptin in 
concentration of 0.1 ng/mL (diluted with 100 mM buffer 
Tris, pH 8) and 10 μg/mL Diprotin A were used as standard.   
G. Statistical Analysis 
The recorded data which represent the average of 
replication were subjected to an one-way analysis of 
variance (ANOVA), and Tukey’s HSD (Honestly Significant 
Different) or Tukey’s studentized range test was ensued 
subsequently  in order to rule the significant level of p < 0.05 
between data in statistically.  
III. RESULT AND DISCUSSION 
A. The Fish Bone Gelatin from Pangasius catfish 
The gelatin existance in clear exracted solution was 
confirmed through the molecular weight (MW) range 
recognition using SDS-PAGE, also the hydroxyproline 
content and the gelatin yield. It is re-play as same as our 
previous research [15], [23], [25], but it is needed to be re-
test in order to justify that the gelatin are presence in the 
extracted solution. The protein pattern of fish bone gelatin 
showed at Figure 1. with MW of >245 kDa and 100-140 kDa. 
The hydroxyproline and gelatin yield are 12.90±1.03 mg/g 
and 5.11±0.02 % respectively. These three indicators have 
been sufficient in justify that the extraction process was 
fruition.  
The gelatin has three form;  α-chain gelatin (with MW 
~120 kDa) , β-chain (dimer of α-chain, MW ~250 kDa) 
gelatin and Ɣ-chain (trimer of α-chain, MW >250 kDa) 
gelatin. Gelatin derived from fish bones were dominated by 
β and α form. The α-chain gelatin is divided to α1 and α2 
form whereas MW of α2 is smaller than α1 [28]. Previous 
studies have been confirmed that gelatin from bones of 
Pangasius catfish [21], Lizardfish [29], Grass carp [30], Red 
snapper and Grouper fish [17], King Weakfish [28] as well 
as Channel catfish [31] have MW in range of β, α1 and α2 
chain through vertical electrophoresis identification. 
Furthermore, our previous studies also found that gelatin 
extracted from bone of Indonesian Pangasius catfish has 
shown their band in area with MW of 100-200 kDa and > 
225 kDa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1  Electroforegram fish bone gelatin from Pangasius catfish (FB) and 
marker protein (M) 
 
The next indicators were hydroxyproline concent and the 
gelatin yield. Hydroxyproline is amino acid which abundant 
in gelatin and it has a role as differentiator during analyisis 
in order to describe of this type of protein compared another, 
despite it was a main factor that influencing of gelatin 
physical characteristic. The hydroxyproline content in 
Indonesian Pangasius catfish extracted by pineapple liquid 
waste with different pre-treatment times was 10.9 – 16.3 
mg/g [12] and extracted by citric acid was 18.1 mg/g [23]. 
Hydroxyproline contents of the gelatin derived from bone of 
Tiger-toothed croaker (Otolithes ruber), Pink perch 
(Nemipterus japonicus) [24] and skin of Tilapia [32] were 
7.51, 7.41 and 8.44 mg/g, respectively. In addition, the 
gelatin yield was quantified to indicate of resulting dry 
gelatin based on weigth of bone.  Fish bone gelatin yield 
have been reported to vary among difference species, Tiger-
toothed croaker was 4.57%, Pink pearch of 3.55% [17], 
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Pangasius catfish was 13.86% [21], Red snapper was 9.14% 
[24], Lizardfish of 8.9% [29],  Channel catfish of 8.43% [31], 
and Nila tilapia of 2.4% [33]. For production of biopolymer, 
the gelatin yield is important, however for medical use, the 
bioactivities and protein concentration are essential.  
B. Hydrolysate Gelatin Preparation Before Fractination 
Hydrolysis of fish bone gelatin was by enzymatic 
hydrolysis using Flavourzyme, a protease (exo- and 
endopeptidase complex) which has been proven produce 
bioactive peptide with higher bioactivities against DPP-IV. 
Degrees of Hidrolysis (DHs) were measured on one 
representative enzyme/substrate [E/S] concentration and 
incubation time. It was confirmed that the fish bone gelatin 
hydrolyzed through each ratio of concentration. The DHs of 
the gelatin hydrolysates obtained by all concentration were 
increased with the increment of E/S ratio. The DH of 
hydrolysate with E/S ratio 3, 6, and 9 % at 4 hours 
incubation were 31.13±0.6, 43.60±2.5 and 59.32±3.6%, 
respectively. These values were significant different each 
other (p <0.05). DHs of fish bone gelatin for 4 hours 
incubation are shown in figure 2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2  DH of Pangsius catfish bone gelatin hydrolyzed with Flavourzyme at 
various E/S ratios during 4 hours incubation time. 
 
DH of hydrolysates derived from tuna juice were 19.4 and 
23.6% by enzyme Protease XXIII (from Aspergillus melleus) 
and Orientase 9N (from Bacillus subtilis) respectively during 
6 hours incubation time at E/S ratio of 3.68%. These 
hydrolysates having inhibitory activity against DPP-IV of 
39.5 and 38.8% respectively [34]. Study conducted by Li-
Chan et al. shown that DH of fish skin gelatin using 1% 
Flavourzyme (E/S ratio) was 28.3%, it is lower than 
Alcalase and Bromelin, and at E/S ratio 6%, the DH was 
slightly higher than other comparative enzymes which was 
reached of 42.5% and it was produced hydrolysate with 
higher inhibitory activity toward DPP-IV. Patent WO 
2006/068480 has demonstrated that protein hydrolysates 
with DHs of 20-40% were possessed referrable and 
preferable for DPP-IV inhibitory activities [19]. Liu et al. 
stated that the DPP-IV activity is determine by the molecular 
size or structure and hydrolysate sequences [35], not depend 
on the DHs.  
The extracted fish bone gelatin (without hydrolysis) 
showed that the percent of inhibition against DPP-IV about 
8.37%. Our previous study has been shown that fish bone 
has a percent inhibition in range of 18.2-21.8% through 10-
1000 times smaller Sitagliptin (standard) concentration 
compared this study. In this work, the hydrolysate from 9% 
E/S ratio along 4 hours incubation showed percent of 
inhibition of 80.41%, and it was the greatest percent of 
inhibition toward DPP-IV than other E/S ratio. It is only 
difference of 20% compared 0.1 ng/mL Sitagliptin as 
positive control. Hydrolysates from E/S ratio of 3% with 
incubation time 4 hours and 6 hours also having percent of 
inhibition above of fifty percent which are 51.15% and 
58.72%, respectively, and those no significant different (p < 
0.05). Percent of inhibition hydrolysate by E/S ratio of 6% 
for 4 hours incubation was 41.38%, and it was declined 
slowly by the increasing of hydrolysis time. In this study, 
concluded that the reaction for hydrolysis preferable at 4 
hours. In overall, hydrolysis process was gradually increase 
the value of percent of inhibition on fish bone gelatin. 
Previous studies were shown that the inhibition rate of 
hydrolysate gelatin derived from skin of salmon, halibut, 
hake, tilapia and milkfish were increased significantly than 
before hydrolysis. Those were about 10% or below before 
enzymatic hydrolysis, whilst after hydrolysis with 
Flavourzyme, they have inhibitory activity above of 20% in 
average and became reach a peak in 48.1%. Hydrolysates 
gelatin from skin of salmon were above of 40% by E/S ratio 
of 1, 2, 3 and 6% at 4 hours incubation [19]. Hydrolysates 
gelatin from skin of halibut and hake were around of 20%, 
30% and 40% in inhibition activity for 4 hours incubation at 
E/S ration 1, 3 and 5% respectively. They inhibition rate 
were stable at various of hydrolysis times (4, 6 and 8 hours). 
In addition, hydrolysates gelatin from skin of tilapia and 
milkfish were around mean of 30%, 40% and 45% for 
inhibit the DPP-IV activity by same ratio of E/S namely 1, 3 
and 5% respectively. The inhibitory acitivity those fish 
based gelatin were also remain stable at difference 
incubation period (4, 6, and 8 hours) [16]. All of those 
previous research were used Diprotin A as standard, 
however this study was used Sitagliptin as a standard DPP-
IV inhibitor. Nongonierma and FitzGerald was used 0.006 
and 0.03 ng/mL sitagliptin previously as standard in 
determination inhibitory activity drug interaction with whey 
hydrolysate against DPP-IV [36]. Actually, the value of IC50 
of Sitagliptin is better namely ~20 nM [37] , whilst the IC50 
of Diprotin A is 24.7 μM [19].  
Before fractination, the protein identification was done by 
SDS-PAGE to ensure that the gelatin hydrolysate is exist in 
the solution and not totally degraded. It is critical because in 
the fractination stage, the gelatin hydrolysate is separated 
and fractionated to become smaller molecule. The activity of 
fraction is potentially disappear if the procedure of this stage 
is improperly means that the bioactive peptide is uncollected.  
Fig. 3 depicted that the fish bone gelatin before hydrolysis 
and after hydrolysis. Based on Fig. 3 shows that the 
distribution pattern of gelatin from bone of pangasius catfish 
is changing, where are around 100-225 kDa before 
hydrolysis to become ≤ 50 kDa after hydrolysis. It is mean 
that the hydrolysis stage has been successful whitout 
eliminate the gelatin. This identification also to confirm the 
data in Fig. 2. 
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 Fig. 3 Electroforegram fish gelatin hydrolysate derived from E/S ratio of 9% 
for 4, 6, and 8 h hydrolysis time. M=marker protein, FB=fish bone gelatin 
(whitout hydrolysis) 
C. DPP-IV Inhibitory Activity of UF fraction 
Inhibition rate of UF fraction (≤3 kDa and >3 kDa) 
hydrolysates from fish bone gelatin are shown in Fig. 4 and 
Fig. 5. Fig 4 illustrates percent of inhibition UF fraction of 
each hydrolysates (in various of E/S ratio and time of 
hydrolysis), and Fig 5 depicts percent of inhibition 
accompanied with hydroxyproline concent of UF fraction 
which are highest in their own E/S concentration ratio.  The 
result showed that percent of inhibition of the fraction >3 
kDa higher than those fraction ≤3 kDa. For UF fractions 
of  >3 kDa, percent of inhibition were climbed up moderatly 
by the increasing of E/S ratio, while for UF fractions of ≤3 
kDa from different E/S ratio and hydrolysis time were 
categorized as stable in DPP-IV inhibition. The fractions ≤3 
kDa have percent of inhibition between 4.51±0.86 to 
8.36±0.92% with  insignificant differences (p < 0.05). The 
fraction  >3 kDa  had percent of inhibition of 25.48±1.92 - 
84.83±12.38%. There were significant different among UF 
fraction from E/S ratio 3, 6 and 9%. The highest percent of 
inhibition is UF fraction >3 kDa from E/S ratio 9% and 4 
hours hydrolysis. It was insignificant compared fraction >3 
kDa from E/S ratio 9% and 6 hours hydrolysis. Fig. 5 shows 
that no correlation between hydroxyproline content and 
inhibitory activity of fraction gelatin. UF fraction ≤3 kDa 
contain hydroxyproline 70 – 97.27 mg/g, and UF fraction >3 
kDa have hydroxyproline 81.36 – 160.91 mg/g. According 
to Nongonierma and  FitzGerald, inhibitory activity of 
peptide against DPP-IV is depend on amino acid Proline and 
Alanin existency [5]. 
 
 
Fig. 4  Percent of inhibition UF fractions of gelatin derived from bone of 
Pangasius catfish against DPP-IV. The percent of inhibition was determined 
by using Sitagliptin (0.1 ng/mL) as standard. Bars with different letters are 
significantly different at p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5  Percent of inhibition and hydroxyproline concent of  UF fraction ( ≤3 
kDa and >3 kDa) derived from hydrolysates gelatin of different E/S ratio. 
Hydroxyproline quantified using hydroxyprolin assay kit, with standard 
ranging of 0.2–1 μg/mL. The percent of inhibition toward DPP-IV was 
determined by using 0.1 ng/mL Sitagliptin as standard. Bars with different 
letters are significantly different at p < 0.05. 
 
Study conducted by Li-Chan  et al., Huang et al., and 
Wang et al. showed that the inhibitory activity of fish gelatin 
hydrolysates facing DPP-IV were higher after ultrafiltration. 
The peptides of salmon skin gelatin within the <1 kDa UF 
fraction had DPP-IV inhibition rate of 61.2%, although 
the >2.5 and 1−2.5 kDa fractions demonstrated inhibition 
rates of 29.6 and 43.2%, respectively [19]. Fraction of <1.5 
kDa of  gelatin  hydrolysate from skin of halibut by E/S ratio 
5% and 4 hours hydrolysis time was 38.2%, which was 
slightly higher than fraction from skin of hake but 
insignificant difference (p<0.05). Furthermore, fraction of 
<1.5 kDa of gelatin hydrolysate derived from skin of tilapia 
by E/S ratio 6% and 6 hours of hydrolysis period was 51.2% 
and it was significant difference (p<0.05) compared fraction 
of milkfish skin hydrolysate which was higher than UF 
fraction of hake and halibut, but lower than UF fraction of 
tilapia. All of those fractions were originated from gelatin 
hydrolysis using Flavourzyme [16] 
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Fig. 6  Protein concentration of UF fraction of fish bone gelatin hydrolysate 
(at 4 hours hydrolysis). Bovine serum albumin (BSA) at 0.1-1.0 mg/mL 
used as standard. Bars with different letters are significantly different at p < 
0.05. 
 
In addition, the inhibition rate is not the only one of key 
factor to determine and discover a bioactivities of peptide, 
while the other important is protein concentration. It was 
used as base on effectivity establishment of bioactive peptide. 
The peptide with high bioactivities value and low of protein 
content is preferable [38]. So that, in this study also 
quantified the protein concent of UF fractions. The protein 
concentration has been measured on various E/S ratio of 
concentration at the similar time of hydrolysis (4 hours). 
Time of hydrolysis for 4 hours was selected regarding their 
superiority in resulting of hydrolysate as well as  UF fraction. 
Fig. 6 presents the total protein of fraction of gelatin 
hydrolysate from bone of Indonesian Pangasius catfish and 
the solution pictures.  
Fig. 6 illustrated that protein content in UF fractions  >3 
kDa were cosiderably higher than UF fractions  ≤3 kDa. The 
fraction >3 kDa fish bone hydrolyate from E/S ratio 9% and 
4 hours hydrolysis time namely 2.36 mg/g. It was higher and 
siginificant different (p <0.05) than other fractions of 
hydrolyate from different E/S ratio (3 and 6%, at 4 hours 
hydrolysis). Based on these facts, we definitely agreed that, 
generally, DPP-IV inhibitory activity of a compound or a 
protein is depend on the protein composition. Li-Chan et al. 
concluded that the inhibition activity of bioactive peptide 
from fish gelatin hydrolysate influced by their amino acid 
composition, molecular weight and hydrophobicity [19]. In 
addition, Huang et al. mentioned that the inhibition rate of 
tuna juice hydrolysates against DPP-IV were determined by 
composition and sequence of amino acid but not the length 
of peptide [34]. Gelatin hydrolysates derived from warm-
water fish possessed better in vitro and in vivo DPP-IV 
inhibitory activity than those of cold-water fish [16]. 
Sort of contradiction showed in this study where are the 
smaller fractions (≤3 kDa) have lower inhibition rate than 
fraction of >3 kDa. Whilst the opposite condition was 
happened on most of past studies, where are the smaller 
fraction present highest inhibitory activity. For instance; the 
inhibition rate of  UF fraction <1.5 kDa from fish skin 
hydrolysate of nila, hake, halibut and tilapia were about 40-
60%, at the same time their UF fraction  1.5-2.5 kDa 
and >2.5 kDa were below 20% [16]. Then, the UF fraction 
<1.5 kDa from gelatin hydrolysate of salmon skin was over 
60%, while they UF fraction  1.5-2.5 kDa and >2.5 kDa 
were below 50% and around 30% [19], respectively. Thus, 
the statement related the correlation between the molecular 
weight (MW) with DPP-IV inhibition can not be fully 
accepted. In addition, study operated by Huang et al. (2014) 
which is using porcine gelatin hydrolysate was described 
that fraction <1.5 kDa and 1.5-2.5 kDa had similar inhibition 
rate of 35% roughly [39]. Study conducted by Hsu et al. 
(2013) found that inhibition rate of fraction 1.5-2.5 kDa 
from porcine gelatin hydrolysate was slightly higher than 
fraction <1.5 kDa [40]. Therefore, it will strengthening and 
persuing the theory toward role of amino acid composition 
and sequence on DPP-IV inhibitory activity and eliminating 
the effect of MW.     
D. DPP-IV Inhibitory Activity of GF fraction 
The UF fraction >3 kDa (from E/S ratio 9%) has the 
higher activity, so this fraction was separated further. Each 
eluted solution from gel filtration sephadex G-25 coloumn 
was collected and then measured for their protein profile. 
Figure 7 depicts the protein profile of seventy subfraction 
which is eluted from gel filtration stage. Based on the 
protein profile, it is known that the protein began appeared 
in the 13th subfraction, and then dropped again in the 
subfraction number of  50. There was no identification at all 
in the subfraction above 60. Therefore, the subfraction 
collected that is, starting from the 13th to the 60th number 
which is divided into five gel filtration (GF) fractions 
namely F1-F5. Each fractions then quantified their activity 
as DPP-IV inhibitors. The activity of GF fraction againts 
DPP-IV presented in Figure 8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7  Elusion profile UF fraction >3 kDa from E/S ratio 9% and 4 hours 
hydrolysis separated with gel filtration coloumn on Sephadex G-25. F1= 
subfraction number 13-18, F2= no. 19-27, F3= no. 28-31, F4= no. 32-43 
and F5=no. 44-60. 
 
The inhibitory activity of GF fraction in this study is in 
range of 11.08 – 25.10% (using 0.1 ng/mL sitagliptin as 
standard) and 8.01 – 20.92% (using 10 μg/mL diprotin A as 
standard). The inhibitory activity of these fraction was lower 
than UF fraction. The main factor that might be influence 
this slightly reduction fact is the gelatin 
hydrolysate/polypeptide concentration, where are in the UF 
fraction, the liquid fraction more concentrated, while in the 
GF fraction, the solution is aquaeous or thinner because 
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aquabidest addition as mobile phase. Study by Huang et al. 
found that the GF fraction of protein derived from tuna was 
below 10% until reach a peak at 39.5% [34]. In addition, the 
purified fraction of gelatin hydrolysate derived from salmon 
skin and porcine gelatin were around 15%-68% and 26.7-
64.6%. However, these gelatin fractions are fractionated and 
eluted using high performance coloumn chromatography 
(HPLC) instrument [19], [40].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8  DPP-IV inhibition activity gel filtration (GF) fraction separated 
using Sephadex G-25. Percent of inhibition quantified by two standard; 
Sitagliptin (0.1 ng/mL) and Diprotin A (10 μg/mL). Bars with different 
letters are significantly different at p < 0.05. 
IV. CONCLUSIONS 
This study has clearly demonstrated UF and GF fractions 
of fish bone gelatin hydrolysate have activity as inhibitor of 
DPP-IV. The UF fraction >3 kDa which are hydrolyzed by 
E/S ratio of 9% for 4 hours incubation time and GF fraction 
4 (F4) were potent as an inhibitor agent of DPP-IV. This 
study provides an outlook on the gelatin hydrolysates from 
bone of Pangasius catfish whereas it was the greates source 
of gelatin with high gelatin and extraction yield as well as 
superior physico-chemical characteristic.  
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